Markets.com Logo

VKTX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    25.462$
  • Previous Close
    25.7123$
  • 52 Week Change
    62.81$
  • Day Range
    -0.25$
  • 52 Week High/Low
    18.92$ - 81.7295$
  • Dividend Per Share
    --
  • Market cap
    2 889 M$
  • EPS
    -0.58
  • Beta
    0.666
  • Volume
    --

About

VKTX.US represents the stock of Viking Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders. The company's pipeline includes VK2809, a selective thyroid hormone receptor beta agonist being developed for non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), and VK0612, an oral drug candidate in Phase 2 clinical development for type 2 diabetes.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Clinical Trial Results: Positive data boosts investor confidence, driving up demand and price. Negative or inconclusive results often lead to a stock decline.

Regulatory Approval: FDA approval for VKTX's drug candidates is a major catalyst. Rejection or delays negatively impact the stock.

Competition: Competing drugs and treatments can affect market share and pricing power, influencing VKTX's stock value.

Market Conditions: Overall market sentiment, sector trends, and economic factors influence investor risk appetite and impact VKTX's stock.

Financial Performance: Revenue, profitability, and cash flow impact investor perception and valuation of VKTX.

Partnerships and Collaborations: Strategic partnerships can provide validation and funding, boosting the stock price. Termination of partnerships can have the opposite effect.

News and Announcements: Company specific news, presentations at conferences, and media coverage drive short-term price volatility.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--